Navigation Links

Biology Technology

Biotech Stocks on Investors' Radar -- Northwest Biotherapeutics, ACADIA Pharma, Acorda Therapeutics, and Ultragenyx Pharma

NEW YORK , December 5, 2016 The U.S. Biotechnology industry is the leading Biotech player worldwide, with almost $108 billion of revenue and some $890 billion of total market value. In 2013, around $170 billion were spent on global biopharmaceuticals, and this figure is expected to exceed $220 billion by 2017. This morning, has lined up these four equi... [Comments]

Five-year Extension for Innovative Federal R&D Programs is Good News for Photonics, say SPIE Leaders

BELLINGHAM, Washington, USA (PRWEB) December 02, 2016 A proposed five-year extension for programs strengthening the role of innovative U.S.-owned and -operated small businesses in federally funded research and development is welcome news for the photonics community, say leaders of SPIE, the... [Comments]

uBiome Awards Microbiome Impact Grant to Explore Effects of Heavy Drinking and Smoking on Oral Microbiome

San Francisco, CA (PRWEB) December 03, 2016 Microbial genomics leader uBiome is awarding in-kind scientific grants to ground-breaking microbiome studies. A microbiome impact grant award has been made to Dr. Renato Polimanti of Yale University School of Medicine, who will study the effect of h... [Comments]

Bioengineering Innovations Show Promise for Improving Treatments and Drug Delivery

SAN DIEGO , Dec. 3, 2016  In five studies being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego , researchers are applying advanced biomedical engineering methods to improve the delivery of life-saving treatments to patients with a variety of medical conditions. These new methods are designed to... [Comments]

SystemOne and Daktari Announce Partnership to Bring Connected Diagnostics to Developing World

SPRINGFIELD, Mass. and CAMBRIDGE, Mass. and CAPE TOWN, South Africa , Dec. 4, 2016 SystemOne, a company focused on connecting diagnostics and providing connected diagnostics software platforms for the developing world, and Daktari Diagnostics, a company focused on making "Anywhere. Care.™" a reality with its portable and ultrasensitive immunoassay-based CarePlatform™,... [Comments]

AxioMed Expanding International Presence with Visit to Swiss Surgeons

(PRWEB) December 02, 2016 In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in Woburn, MA to soon resume cervical and lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet with surgeons who ar... [Comments]

11th Double Helix Medals raises $4.3 million for biomedical research and education at Cold Spring Harbor Laboratory

COLD SPRING HARBOR, N.Y. , Dec. 2, 2016 More than $4.3 million was raised last night at Cold Spring Harbor Laboratory's (CSHL) 11th Double Helix Medals dinner ( DHMD ). The gala was held at the American Museum of Natural History (AMNH) in New York City and honored Alan Alda and P. Roy Vagelos for their contributions, respectively, to health and medicine... [Comments]

Groundbreaking MMRF CoMMpass Study(SM) Affirmed as Premier Genomics Data Set in Multiple Myeloma

NORWALK, Conn. , Dec. 2, 2016  The Multiple Myeloma Research Foundation (MMRF) today announced that 19 research presentations from the MMRF CoMMpass Study SM —the largest and most comprehensive study driving new genomic insights and accelerating precision medicine in multiple myeloma—will be presented at the 58 th American Society of Hematology (ASH) Annual Meeting &... [Comments]

Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab

THOUSAND OAKS, Calif. , Dec. 2, 2016 Amgen (NASDAQ: AMGN ) and Allergan plc. (NYSE: AGN ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ABP 215, a biosimilar candidate to Avastin ® (bevacizumab). The companies believe this submission is the first bevacizumab biosimilar application submitted to the... [Comments]

Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board of Directors

LOS ANGELES , Dec. 2, 2016 CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research and development company specializing in oncology, today announced the appointment of Earl Warren Brien , M.D., a noted sarcoma surgeon, industry consultant, and private healthcare investor, to its Board of Directors. "Dr. Brien is a healthcare leader with clinical and strategic expe... [Comments]

Global Nanobiotechnology Report 2015-2025 - Focus on Applications, Markets and Companies with Profiles of 250+ Companies - Research and Markets

DUBLIN , Dec 2, 2016 Research and Markets has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering. An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug developmen... [Comments]

Medicine Technology

Research and Markets - Global Spinal Implants Market to Reach $17.27 Billion by 2021 - Key Vendors are Globus Medical, RTI Surgical & Stryker Corporation

DUBLIN , Dec 5, 2016 Research and Markets has announced the addition of the "Spinal Implants and Surgical Devices Market - Global Forecast to 2021" report to their offering. The global spinal implants and surgical devices market is estimated to reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 to 2021. Factors such as the presence of a la... [Comments]

Global Female Fertility and Pregnancy Rapid Test Market to Growe 4% by 2022 - Easy to Use at Home Diagnostic Devices Fueling Growth - Research and Markets

DUBLIN , Dec 5, 2016 Research and Markets has announced the addition of the "Global Female Fertility and Pregnancy Rapid Test Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering. The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% during 2016-2022. The global... [Comments]

Seno Medical Instruments to Present Updated Data from Pivotal European Study at 2016 San Antonio Breast Cancer Symposium

SAN ANTONIO , Dec. 5, 2016  Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, today announced that it will present data from its European MAESTRO post-market surveillance and clinical follow-up study at the 2016 San Antonio Breast Cancer Symposium (SABCS) ta... [Comments]

BioLineRx Presents Positive Phase 2a AML Study and Mechanism-of-Action Data for BL-8040 Oncology Platform at ASH 2016

TEL AVIV, Israel , December 5, 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase 2a correlative data, as well as detailed mechanism-of-action data, for BL-8040, the Company's leading oncology platform at the ongoing 58th American S... [Comments]

PharmaBoardroom Releases 'Healthcare and Life Sciences Review Switzerland'

LONDON , December 5, 2016 PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life Sciences Review 2016 . This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland ; a country located at the heart of Europe , home to some of the world's most important international health... [Comments]

Mission Therapeutics Appoints Colin Goddard as Chairman

CAMBRIDGE, England , December 5, 2016 M ichael Moore Transitions to Deputy Chairman   Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and other diseases, announces that Dr Colin Goddard has been appointed as non-executive Chairman, effective... [Comments]

Non-Invasive Prenatal Testing (NIPT) Market Worth $5.5 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO , December 5, 2016 The global  non-invasive prenatal testing market  is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that can serve as an intermediate step between serum screening and invasive diagnostic testing to determine the likel... [Comments]

AOP Orphan and PharmaEssentia Announce Pivotal Phase III Results for Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2016

VIENNA and TAIPEI, Taiwan , Dec. 5, 2016 At 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) PROUD-PV demonstrated a significantly better safety and tolerability profile of ropeginterferon alfa-2b versus HU AOP will submit the data from PROUD-PV and the ongoing long-term follow-up tri... [Comments]

Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis

CAMBRIDGE, Mass. , Dec. 4, 2016 Blueprint Medicines Corporation (NASDAQ: BPMC ), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced data from its ongoing Phase 1 trial evaluating BLU-285, an investigational medicine for the treatment of patients with advanced systemic mastocytosis (SM). Bluepr... [Comments]

ZIMMER BIOMET (ZBH) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Zimmer Biomet Holdings, Inc.; Encourages all Investors to Contact the Firm for Information

SAN DIEGO , Dec. 3, 2016 Johnson & Weaver, LLP announces that a class action complaint was filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH )  securities during the period between September 7, 2016 through October 31, 2016 (the "Class Period"). Zimmer Biomet provides musculoskeletal healthcare products and solutions. It designs, manufacture... [Comments]


NEW ORLEANS , Dec. 2, 2016  Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Lannett Company, Inc. (NYSE: LCI ). On November 3, 2016, Bloomberg published an article titled "U.S. Charges in Generic-Drug Probe to Be Filed by Ye... [Comments]

(Date:12/2/2016)... , December 2, 2016 The immunohistochemistry ... growing at a CAGR of 7.3% during the forecast period of ... and diagnostic laboratories segment accounted for the largest share of immunohistochemistry ... ... on global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... magnet Voice Coil Actuator with a flexure design that ensures high alignment accuracy ... cost-effective pricing and is ideally suited where extreme precision is required, such as ...
(Date:11/30/2016)... November 30, 2016 The global ... players hold a dominant share in the overall market. ... International, Inc., and Merck KGaA, held a lion,s share ... Market Research observes that these companies are expected to ... products that are do not require rabbit pyrogen testing ...
(Date:11/30/2016)... Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer ... addition of its newest plasma collection center located at ... The 15,200 square foot state-of-the-art facility officially opened its ... the total number of BPC,s plasma collection centers to ... Chief Executive Officer said "We are pleased to become ...
Breaking Biology Technology:
(Date:12/2/2016)... 2, 2016 Persistence Market Research ... its upcoming report titled, "Global Market Study on Cardiac Pacemaker: ... of -1.4% between 2016 and 2024". The global cardiac pacemaker ... and this is likely to decline to US$ 3923.8 ... cardiac pacemaker market is anticipated to exhibit a declining ...
(Date:12/2/2016)... Dec 2, 2016 Research and Markets has ... Development, Growth and Demand Forecast to 2022" report to their offering. ... , , ... billion in 2015, and it is expected to grow at a CAGR ... expected to witness faster growth during the forecast period, a CAGR of ...
(Date:12/2/2016)... Spain , Dec. 2, 2016 In ... natural sources apart from those derived from C. sativa, ... the Universita` di Napoli Federico II , the ... created the first comprehensive, critical, integrated and unified inventory ... The article focuses on the remarkable chemical and ...
Breaking Medicine Technology: